je.st
news
GlaxoSmithKline to pay $105 million to states over drug marketing claims
2014-06-05 16:47:37| Biotech - Topix.net
GlaxoSmithKline has agreed to pay $105 million to 44 states to settle charges it improperly marketed the asthma drug Advair and the antidepressants Paxil and Wellbutrin.
Tags: states
pay
marketing
million
Category:Biotechnology and Pharmaceuticals